Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, ... Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products (OAD). Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management (NovoSeven(R) RT), growth hormone therapy, hormone replacement therapy and other products. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 6.04 | 7.74855676716 | 77.95 | 94.05 | 77.95 | 27815 | 87.10636932 | CS |
4 | -2.06 | -2.39395700174 | 86.05 | 94.05 | 77.95 | 38658 | 84.79337062 | CS |
12 | -26.01 | -23.6454545455 | 110 | 114 | 77.95 | 58325 | 101.74722493 | CS |
26 | -48.1 | -36.4145658263 | 132.09 | 141.19 | 77.95 | 45422 | 109.61384634 | CS |
52 | -24.01 | -22.2314814815 | 108 | 149.55 | 77.95 | 47250 | 121.18544205 | CS |
156 | 34.74 | 70.538071066 | 49.25 | 149.55 | 46.9 | 29895 | 98.48511513 | CS |
260 | 53.415 | 174.701553557 | 30.575 | 149.55 | 24.205 | 24624 | 82.68350748 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales